Conflict-of-interest disclosure
We coordinate and sell access to the treatments described on this site. That is a conflict of interest, and it is stated here rather than left for the reader to infer. This page sets out what we earn from, who is affiliated with whom, and the rules that keep those interests out of the evidence.
Maintained by the StemCell Longevita editorial team · Medically reviewed by Prof. Dr. Erdal Karaöz Team, Professor of Histology and Embryology ·
What we are, commercially
StemCell Longevita is an international patient coordination platform. We earn revenue when a patient proceeds with treatment at the partner facility, and we have a direct financial interest in the therapies described across this website. We are not a regulator, an academic body, or an independent review organisation, and we do not present ourselves as one.
Declared interests
| Party | Interest | Disclosure |
|---|---|---|
| StemCell Longevita | Revenue from coordinated treatment programmes | Declared on every commercial page; pricing published openly. |
| Prof. Dr. Erdal Karaöz | Medical director and scientific lead of the laboratory whose products are described here; academic posts held in parallel | Full affiliations and periods published on his profile page. |
| Partner hospital and laboratory | Paid providers of the clinical and manufacturing services described | Named openly on facility and laboratory pages. |
| Editorial team | Salaried; no per-conversion or per-article commercial incentive | No bonus is tied to enquiry volume from a specific medical page. |
Rules that limit the conflict
- Evidence ratings follow the published hierarchy and may not be softened for commercial reasons.
- Pages must state where evidence is weak, absent or negative, including failed trials.
- We do not publish success rates, outcome percentages or testimonials we cannot evidence.
- We do not pay for editorial coverage, reviews, or ratings, and we do not accept payment to feature a treatment.
- Candidacy content must include the reasons a patient would not be suitable, not only the reasons they would.
- Advertising and sponsored placement, if ever used, would be labelled on the page itself.
Funding and independence of review
The site is funded entirely by the company's own operations. No pharmaceutical company, device manufacturer or patient-recruitment agency funds content on this site. Medical review is performed by our named reviewer, who is affiliated with the clinical programme; that affiliation is itself a limitation and is why every clinical claim is additionally tied to an external, linkable source that a reader can check independently.
How to raise a concern
If you believe a page overstates a benefit or hides a commercial interest, contact us with the page and the sentence. Concerns are logged, the page is re-reviewed, and any correction is reflected in the page's review date. Our full process is in the editorial standards and evidence methodology.
Frequently asked questions
Does the medical reviewer benefit financially from treatments described here?
He is the medical director of the clinical and laboratory programme, so yes — that relationship is disclosed on his profile and is the reason external sources are required for every clinical claim.
Do you accept sponsored content?
No. No page on this site has been paid for by a third party, and we do not sell placement in guides, comparisons or reports.
Are your cost figures independent?
They are our own published prices plus publicly sourced comparisons, with methodology and sources shown in the annual cost report. They are original data, not a neutral market survey.
Editorial standards
Who writes, who reviews, how often pages change and how corrections are handled.
How we evaluate evidence
The source hierarchy and the five-part rating shown on every condition page.
Conflict-of-interest disclosure
Our commercial interests, stated plainly, and the rules that limit them.